Ogivri

List of products in the National Drug Code with proprietary name ogivri. Trastuzumab is used to treat certain breast or stomach cancers that produce more than the normal amount of a certain substance called HER2 protein. Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This monograph is about the following trastuzumab products: trastuzumab, trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
67457-847Ogivri TrastuzumabKitMylan Institutional LlcHuman Prescription Drug
67457-991Ogivri TrastuzumabInjection, Powder, Lyophilized, For SolutionIntravenousMylan Institutional LlcHuman Prescription Drug
83257-001Ogivri Trastuzumab-dkstInjection, Powder, Lyophilized, For SolutionIntravenousBiocon Biologics Inc.Human Prescription Drug
83257-003Ogivri Trastuzumab-dkstInjection, Powder, Lyophilized, For SolutionIntravenousBiocon Biologics Inc.Human Prescription Drug
83257-004Ogivri Trastuzumab-dkstKitBiocon Biologics Inc.Human Prescription Drug